Role of Vitamin D Receptor Activation in Racial Disparities in Kidney Disease Outcomes

Utibe Essien, Narender Goel, Michal L. Melamed

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

African Americans have lower 25-hydroxyvitamin D (25(OH)D) levels compared with whites. African Americans also have a higher risk of developing albuminuria and end-stage renal disease but a lower risk of death once they commence hemodialysis compared with whites. Vitamin D levels have been associated with multiple outcomes including albuminuria, progression to end-stage renal disease, and all-cause and cardiovascular mortality. In this review, we examine the evidence linking 25(OH)D to outcomes and the possibility that differential 25(OH)D may explain certain racial differences in outcomes.

Original languageEnglish (US)
Pages (from-to)416-424
Number of pages9
JournalSeminars in Nephrology
Volume33
Issue number5
DOIs
StatePublished - Sep 2013

Fingerprint

Calcitriol Receptors
Albuminuria
Kidney Diseases
African Americans
Chronic Kidney Failure
Vitamin D
Renal Dialysis
Mortality
25-hydroxyvitamin D

Keywords

  • Albuminuria
  • Chronic kidney disease
  • Mortality
  • Racial differences
  • Vitamin D

ASJC Scopus subject areas

  • Nephrology

Cite this

Role of Vitamin D Receptor Activation in Racial Disparities in Kidney Disease Outcomes. / Essien, Utibe; Goel, Narender; Melamed, Michal L.

In: Seminars in Nephrology, Vol. 33, No. 5, 09.2013, p. 416-424.

Research output: Contribution to journalArticle

@article{d7ca7f91d8a44f688c600b1841eabcae,
title = "Role of Vitamin D Receptor Activation in Racial Disparities in Kidney Disease Outcomes",
abstract = "African Americans have lower 25-hydroxyvitamin D (25(OH)D) levels compared with whites. African Americans also have a higher risk of developing albuminuria and end-stage renal disease but a lower risk of death once they commence hemodialysis compared with whites. Vitamin D levels have been associated with multiple outcomes including albuminuria, progression to end-stage renal disease, and all-cause and cardiovascular mortality. In this review, we examine the evidence linking 25(OH)D to outcomes and the possibility that differential 25(OH)D may explain certain racial differences in outcomes.",
keywords = "Albuminuria, Chronic kidney disease, Mortality, Racial differences, Vitamin D",
author = "Utibe Essien and Narender Goel and Melamed, {Michal L.}",
year = "2013",
month = "9",
doi = "10.1016/j.semnephrol.2013.07.003",
language = "English (US)",
volume = "33",
pages = "416--424",
journal = "Seminars in Nephrology",
issn = "0270-9295",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Role of Vitamin D Receptor Activation in Racial Disparities in Kidney Disease Outcomes

AU - Essien, Utibe

AU - Goel, Narender

AU - Melamed, Michal L.

PY - 2013/9

Y1 - 2013/9

N2 - African Americans have lower 25-hydroxyvitamin D (25(OH)D) levels compared with whites. African Americans also have a higher risk of developing albuminuria and end-stage renal disease but a lower risk of death once they commence hemodialysis compared with whites. Vitamin D levels have been associated with multiple outcomes including albuminuria, progression to end-stage renal disease, and all-cause and cardiovascular mortality. In this review, we examine the evidence linking 25(OH)D to outcomes and the possibility that differential 25(OH)D may explain certain racial differences in outcomes.

AB - African Americans have lower 25-hydroxyvitamin D (25(OH)D) levels compared with whites. African Americans also have a higher risk of developing albuminuria and end-stage renal disease but a lower risk of death once they commence hemodialysis compared with whites. Vitamin D levels have been associated with multiple outcomes including albuminuria, progression to end-stage renal disease, and all-cause and cardiovascular mortality. In this review, we examine the evidence linking 25(OH)D to outcomes and the possibility that differential 25(OH)D may explain certain racial differences in outcomes.

KW - Albuminuria

KW - Chronic kidney disease

KW - Mortality

KW - Racial differences

KW - Vitamin D

UR - http://www.scopus.com/inward/record.url?scp=84885224296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885224296&partnerID=8YFLogxK

U2 - 10.1016/j.semnephrol.2013.07.003

DO - 10.1016/j.semnephrol.2013.07.003

M3 - Article

C2 - 24119847

AN - SCOPUS:84885224296

VL - 33

SP - 416

EP - 424

JO - Seminars in Nephrology

JF - Seminars in Nephrology

SN - 0270-9295

IS - 5

ER -